Skip to content
Health Hacker Australia
MENUMENU
  • Home
  • Our Services
    • Health Q and A
  • The Science
  • Articles
    • DNA and Genetics
    • eli5 - explain it like i'm five
    • Experimental moleculesMolecules that have been identified as possibly beneficial to healthspan and lifespan. Some of these are in animal trials only or have limited human trials. We will typically not include potentially dangerous molecules and will only include animal trials that show good solid science and a high likelihood of transferring over to human biology.
    • LongevityArticles pertaining to longevity, both healthspan and lifespan.
    • SupplementsCompounds and molecules we add to our diet/body to improve health
  • Shop
    • Recommended Suppliers and Products
    • Cart
    • Checkout
  • Resources
    • Recommended Suppliers and Products
    • Books
    • Podcasts and YouTube Channels
    • News Feeds
  • Community & Account
    • My account
    • Meal Tracker
  • Contact
    • Facebook
  • News & Deals
  • Help & About
    • Accreditations and Memberships
    • Terms and Conditions
    • Privacy Policy

Tag: pathway

Health Hacker Australia > pathway
Muscle wasting disease linked to defective mitochondrial energy and NAD+ biosynthesis pathways – Science Mission

Muscle wasting disease linked to defective mitochondrial energy and NAD+ biosynthesis pathways – Science Mission

Posted on 31/12/2019 by Nathan

“Moreover, results showed that sarcopenia was also associated with reduced levels of enzymes involved in the recycling of NAD+, which acts as a metabolic sensor in the cell and regulates energy production pathways.”

http://sciencemission.com/site/index.php?page=news&type=view&id=health-science%2Fmuscle-wasting-disease&filter=8%2C9%2C10%2C11%2C12%2C13%2C14%2C16%2C17%2C18%2C19%2C20%2C27

Posted in Ageing, Longevity and disease.Tagged Act, energy, longevity, pathway, resultLeave a Comment on Muscle wasting disease linked to defective mitochondrial energy and NAD+ biosynthesis pathways – Science Mission
LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway

Posted on 17/12/201917/12/2019 by Nathan

“PP2A inhibition by LB100 significantly ameliorates hepatic steatosis by regulating hepatic lipogenesis and fatty acid oxidation via the AMPK/Sirt1 pathway. LB100 may be a potential therapeutic agent for NAFLD.”

https://www.wjgnet.com/1007-9327/full/v25/i45/6607.htm

Posted in Other health linksTagged ameliorate, ampksirt, Hepatic, lb, longevity, pathway, PPALeave a Comment on LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
 

Loading Comments...